Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 15 of 25

COMPLETED

Black Patients' Lived Experiences and Perceptions of Skin of Color Clinics

NCT02375659

COMPLETED NA

Sideways Treadmill Training to Improve Paretic Leg Stepping in Persons Post-Stroke

NCT02516176

COMPLETED Phase 4

Ulipristal for Endometriosis-related Pelvic Pain

NCT02213081

COMPLETED

Identification of Novel Circadian Biomarkers

NCT02291003

COMPLETED Phase 2

Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma

NCT02242097

COMPLETED

Long-term Use of Romidepsin in Patients With CTCL

NCT02296398

COMPLETED NA

RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial)

NCT02246660

COMPLETED

Brain, Brainstem, and Spinal Cord fMRI

NCT02356315

COMPLETED NA

Association Between Bolus Rate and the Adequacy of Labor Analgesia Using Timed-intermittent Boluses

NCT02340806

COMPLETED NA

Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation

NCT02579174

TERMINATED NA

Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment

NCT02357784

COMPLETED NA

Evaluation of Centration of Intraocular Lens With Two Settings for Capsulorhexis With Femtosecond Laser

NCT02315456

COMPLETED NA

Mobile Phone Sensing and Outreach as Adjuncts to Internet-Based Behavioral Intervention for Depression

NCT01107041

COMPLETED NA

Promoting the Universal Medication Schedule Via Mobile and EHR Technologies

NCT02248857

TERMINATED NA

CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants

NCT02299206

COMPLETED NA

Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation

NCT02205385

COMPLETED NA

Activity and Nutrition Trial in Lupus to Energize and Renew

NCT02281513

COMPLETED NA

Targeted Reinnervation for Neuromas as a Means to Improve Prosthesis Control in Major Limb Amputation

NCT02316262

COMPLETED

Community Engagement for Early Recognition and Immediate Action in Stroke

NCT02301299

COMPLETED Phase 4

Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial

NCT02013427

COMPLETED

Spatial Orientation and Fiberoptic Intubation Skills in the Novice: A Randomized Controlled Trial

NCT02263300

TERMINATED Phase 4

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

NCT02209545

TERMINATED Phase 1

Stem Cell Transplantation for Stiff Person Syndrome (SPS)

NCT02282514

COMPLETED

Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study

NCT02268513

COMPLETED NA

Advance Planning for Home Services for Seniors

NCT02256072

COMPLETED NA

Community-Clinic Partnership to Promote Physical Activity in South Asian Women

NCT02342535

COMPLETED Phase 2

Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia

NCT02237235

COMPLETED NA

Restricted Convalescence: Outcomes Following Urogynecologic Procedures

NCT02138487

COMPLETED

Pith Moromo 2: Cohort to Study Health Consequences of Food and Nutrition Insecurity During Pregnancy and Lactation

NCT02974972

COMPLETED

Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps

NCT02782793

COMPLETED NA

Endometrial Injury and in Vitro Fertilization Outcomes

NCT02153814

COMPLETED

Quality of Recovery Awake Versus Asleep Craniotomy

NCT02228993

COMPLETED NA

Neuromuscular Mechanisms Underlying Poor Recovery From Whiplash Injuries

NCT02157038

COMPLETED NA

Myoelectric Computer Interface to Reduce Muscle Co-activation After Stroke

NCT03579992

TERMINATED NA

Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies

NCT02447926

TERMINATED NA

Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants

NCT02154984

COMPLETED Phase 2

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

NCT02048722

COMPLETED

Abdominal Ultrasound Assessment in the Post-cesarean Patient

NCT02159105

COMPLETED

Helping Children be Safe Outdoors With Sun Protection

NCT02177006

COMPLETED NA

Reducing Emotional Distress, Enhancing Function and Improving Network Engagement in Adolescent and Young Adult Oncology

NCT02495376

COMPLETED NA

Expanding the Cycle of Opportunity: Simultaneously Educating Parents and Children in Head Start

NCT02234661

COMPLETED Phase 1

BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx

NCT02038010

COMPLETED Phase 1

Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients

NCT02145325

COMPLETED NA

Stability of the Medial Pivot Total Knee Prosthesis

NCT02577978

COMPLETED Phase 2

Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide

NCT02195895

TERMINATED NA

Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes

NCT02121184

COMPLETED Phase 4

C7-T1 Epidural Steroid Injections Versus Targeted Injection for Treatment of Cervical Radicular Pain

NCT02095197

COMPLETED Phase 4

Ultrasound-guided Adductor Canal Block for Total Knee Replacement

NCT02100579

COMPLETED

Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker

NCT02048995

COMPLETED NA

Effect of Local Steroid Application on a Cervical Plate Versus Intravenous Steroids on Dysphagia Following Anterior Cervical Discectomy and Fusion (ACDF)

NCT02577991

← Previous Page 15 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.